Latest Europe News

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Energy Transition Minerals has submitted a binding offer to acquire the Penouta Mine in Spain, a critical asset for Europe’s supply of tantalum and niobium. The outcome hinges on regulatory approvals and competitive bidding.

Victory Metals has secured critical U.S. federal government approval, enabling direct engagement with the Department of Defence and access to substantial funding to advance its heavy rare earths project in Western Australia.

DroneShield is investing $13 million to significantly expand its R&D and manufacturing footprint, aiming to boost annual production capacity nearly fivefold by the end of 2026.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

HITIQ Limited is set to debut its PROTEQT concussion management system in the UK on August 4, 2025, uniquely integrating with NHS 111 telehealth services to offer free medical guidance. This launch marks HITIQ’s first international consumer market entry and a strategic step in its global expansion.

Vulcan Energy Resources has raised €30 million through a strategic placement led by BNP Paribas’ Clean Energy Solutions Fund to advance critical development stages of its Phase One Lionheart lithium project.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

European Lithium has sold 0.5 million shares of Critical Metals Corp for US$1.625 million, underscoring the substantial value of its remaining CRML stake, now valued at approximately US$205 million.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Argent BioPharma has begun supplying its EU-GMP cannabinoid API for drug-resistant epilepsy treatment at University Medical Centre Ljubljana, marking a key clinical and regulatory milestone in Europe.